Trial intelligence / Profile preview

ARCH: Clopidogrel+Aspirin vs Warfarin in Aortic Arch Atherothrombosis

NCT00235248Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Feb 2002
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of clopidogrel, aspirin in brain infarction, Transient Ischemic Attack (TIA), peripheral arterial embolism, sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2002; status: completed.

02

Drugs

clopidogrelaspirin
03

Conditions

brain infarctionTransient Ischemic Attack (TIA)peripheral arterial embolism

Beyond the preview

Go deeper on NCT00235248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00235248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call